Search 7,500+ licensed pharmacies to find the best value, closest location, and fastest turnaround for
.
Diphenhydramine competitively blocks histamine H1 receptors on blood vessels, bronchial smooth muscle, and sensory nerve endings, reducing vasodilation, bronchoconstriction, and itch signaling. It also has anticholinergic and CNS-sedating properties useful in palliative and combination formulas.
Commercial diphenhydramine is OTC, but compounding provides topical formulations for localized itch, suppositories for patients unable to swallow, dye-free and preservative-free capsules for MCAS patients, and custom combination formulas.
Compare up to 7,500 pharmacies across the USA.
Diphenhydramine is one of the oldest and most widely used antihistamines. In compounded form, it offers formulations that commercial products don't provide — including topical preparations for localized pruritus, preservative-free and dye-free capsules for chemically sensitive patients, suppository forms for those with swallowing difficulties or nausea, and combination palliative care formulas.
Diphenhydramine's significant sedating and anticholinergic properties make it useful in palliative care cocktails, nausea/vomiting protocols, and nighttime allergy relief formulations. For MCAS patients, dye-free and preservative-free compounded capsules eliminate problematic excipients found in commercial Benadryl tablets and capsules.
H1 Receptor Blockade
Diphenhydramine competitively and reversibly binds H1 histamine receptors on vascular endothelium, bronchial smooth muscle, and sensory nerve endings. This prevents histamine-mediated vasodilation, capillary permeability, bronchoconstriction, and itch signaling.
Anticholinergic Activity
Diphenhydramine has significant muscarinic receptor antagonism — blocking acetylcholine at parasympathetic effector sites. This produces dry mouth, urinary retention, decreased GI motility, and mydriasis. These same properties make it useful in palliative care antiemetic formulas.
CNS Penetration
As a first-generation antihistamine, diphenhydramine readily crosses the blood-brain barrier by passive diffusion, producing sedation through H1 receptor blockade in the CNS. This property distinguishes it from second-generation antihistamines like cetirizine, which are less lipophilic and cause minimal sedation.
Allergic reactions (urticaria, angioedema), pruritus (generalized and localized itching), acute allergic skin reactions, insomnia, motion sickness, nausea and vomiting, MCAS-related histamine symptoms, palliative care combination formulas (nausea/pain/anxiety), atopic dermatitis (topical use)
Palliative care combination formulas (nausea, anxiety, and pain management), motion sickness prevention, cough suppression (antitussive), mild Parkinson's disease symptom adjunct, extrapyramidal symptom (EPS) management from antipsychotics, topical relief of minor burns and insect bites
Oral (capsule/liquid): 25–50mg every 4–6 hours as needed; max 300mg/day
Topical cream: Apply a thin layer to affected area 2–4 times daily
Suppository: 25–50mg per suppository every 4–6 hours as needed
Pediatric (>2 years): 1.25mg/kg/dose every 4–6 hours (compounded liquid required)
Prescriber adjusts doses based on age, weight, and indication.
MCAS / Allergy Protocol: Start with 12.5–25mg at bedtime to assess sedation tolerance before daytime use. Many MCAS patients use diphenhydramine only as a rescue antihistamine for breakthrough reactions rather than scheduled dosing.
Topical use: Start with a small test area to assess for contact sensitization before broader application.
Palliative formulas: Prescriber-directed dosing based on combination formula components and patient weight.
Dye-free/Preservative-free Oral Capsules — 12.5mg, 25mg, or 50mg capsules compounded without dyes, lactose, or preservatives for MCAS and chemically sensitive patients
Oral Liquid Suspension — typically 12.5mg/5mL, allowing precise pediatric dosing and easy dose adjustment
Topical Cream or Gel — 1–2% diphenhydramine in a skin-compatible base for localized pruritus, insect bites, and contact reactions
Suppository — 25mg or 50mg rectal suppositories for patients with nausea, dysphagia, or impaired oral intake
Palliative Combination Compounds — diphenhydramine combined with other agents (e.g., lorazepam, haloperidol, promethazine) in custom formulas for hospice and palliative care use
Sedation and drowsiness (significant — do not drive or operate machinery), dry mouth, urinary retention, constipation, blurred vision (anticholinergic effects). Not recommended for elderly patients — listed on the Beers Criteria for potentially inappropriate medications in older adults due to increased fall risk and cognitive impairment. Avoid in patients with narrow-angle glaucoma, benign prostatic hyperplasia (BPH), or those taking other anticholinergic medications.
Submit a quote request to find the lowest price. Quotes delivered to your inbox.
Find Lowest Price.png){kind=spacer}
